Gowan acquires Myimethamine’s global interests of Syngenta

Gowan's subsidiary, Gowan Crop, announced that it has entered into an agreement with Syngenta to acquire global interests in the insecticide active ingredient Cyromazine.

The acquisition will strengthen Gowen's core products in vegetables to better meet the needs of growers. The acquisition includes product registration and trademarks TRIGARD® and LEPICRON®, as well as related intellectual property rights and labels. It does not include the CITATION® trademark for ornamental plant use.

The transaction was completed on December 28, 2023, and Syngenta and Gowan will work together over the coming months to facilitate an orderly transition and maintain superior customer service in all regions.

About Cyromazine  

Cyromazine was first developed by the Ciha-Gergy and introduced in the 1960s and 1970s to combat insect pests and diseases. As a triazine insecticide in IRAC Group 17, it plays a role in regulating insect growth and belongs to a new type of high-efficiency, low-toxicity, nitrogen-containing heterocyclic insecticide. It has special physiological activity in controlling the larvae and pupae of diptera insects, and can interfere with molting and pupae, resulting in morphological distortion and inhibition or incomplete emergence of adult insects. So as to achieve the purpose of controlling the reproduction of diptera pests and reducing the number of pests, it is a good ecological pesticide for the prevention and control of diptera insects.